|
1
|
Tonks NK: Protein tyrosine phosphatases:
From genes, to function, to disease. Nat Rev Mol Cell Biol.
7:833–846. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun T, Aceto N, Meerbrey KL, Kessler JD,
Zhou C, Migliaccio I, Nguyen DX, Pavlova NN, Botero M, Huang J, et
al: Activation of multiple proto-oncogenic tyrosine kinases in
breast cancer via loss of the PTPN12 phosphatase. Cell.
144:703–718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin G, Aranda V, Muthuswamy SK and Tonks
NK: Identification of PTPN23 as a novel regulator of cell invasion
in mammary epithelial cells from a loss-of-function screen of the
'PTP-ome'. Genes Dev. 25:1412–1425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ying J, Li H, Cui Y, Wong AH, Langford C
and Tao Q: Epigenetic disruption of two proapoptotic genes
MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas
through hypermethylation of a common bidirectional promoter.
Leukemia. 20:1173–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsu SH, Motiwala T, Roy S, Claus R,
Mustafa M, Plass C, Freitas MA, Ghoshal K and Jacob ST: Methylation
of the PTPRO gene in human hepatocellular carcinoma and
identification of VCP as its substrate. J Cell Biochem.
114:1810–1818. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakamura M, Kishi M, Sakaki T, Hashimoto
H, Nakase H, Shimada K, Ishida E and Konishi N: Novel tumor
suppressor loci on 6q22-23 in primary central nervous system
lymphomas. Cancer Res. 63:737–741. 2003.PubMed/NCBI
|
|
7
|
Fridberg M, Kjellström S, Anagnostaki L,
Skogvall I, Mustelin T, Wiebe T, Persson JL, Dictor M and Wingren
AG: Immunohistochemical analyses of phosphatases in childhood
B-cell lymphoma: Lower expression of PTEN and HePTP and higher
number of positive cells for nuclear SHP2 in B-cell lymphoma cases
compared to controls. Pediatr Hematol oncol. 25:528–540. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denkert C, Schmitt WD, Berger S, Reles A,
Pest S, Siegert A, Lichtenegger W, Dietel M and Hauptmann S:
Expression of mitogen-activated protein kinase phosphatase-1
(MKP-1) in primary human ovarian carcinoma. Int J Cancer.
102:507–513. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao S, Sedwick D and Wang Z: Genetic
alterations of protein tyrosine phosphatases in human cancers.
Oncogene. 34:3885–3894. 2015. View Article : Google Scholar :
|
|
10
|
Nunes-Xavier CE, Elson A and Pulido R:
Epidermal growth factor receptor (EGFR)-mediated positive feedback
of protein-tyrosine phosphatase epsilon (PTPepsilon) on ERK1/2 and
AKT protein pathways is required for survival of human breast
cancer cells. J Biol Chem. 287:3433–3444. 2012. View Article : Google Scholar
|
|
11
|
Boivin B, Chaudhary F, dickinson BC, Haque
A, Pero SC, Chang CJ and Tonks NK: Receptor protein-tyrosine
phosphatase α regulates focal adhesion kinase phosphorylation and
ErbB2 oncoprotein-mediated mammary epithelial cell motility. J Biol
Chem. 288:36926–36935. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang J, Chen X, Liu B and Zhu Z:
Suppression of PTP1B in gastric cancer cells in vitro induces a
change in the genome-wide expression profile and inhibits gastric
cancer cell growth. Cell Biol Int. 34:747–753. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang N, She J, Liu W, Shi J, Yang Q, Shi B
and Hou P: Frequent amplification of TP1B is associated with poor
survival of gastric cancer patients. Cell Cycle. 14:732–743. 2015.
View Article : Google Scholar :
|
|
14
|
Matozaki T, Murata Y, Saito Y, Okazawa H
and Ohnishi H: Protein tyrosine phosphatase SHP-2: A proto-oncogene
product that promotes Ras activation. Cancer Sci. 100:1786–1793.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng LF, Zhang RY, Yu ZH, Li S, Wu L,
Gunawan Am, Lane BS, Mali RS, Li X, Chan RJ, et al: Therapeutic
potential of targeting the oncogenic SHP2 phosphatase. J Med Chem.
57:6594–6609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li SM: The biological function of shp2 in
human disease. Mol Biol (Mosk). 50:27–33. 2016.In Russian.
View Article : Google Scholar
|
|
17
|
Huang J, Yao L, Xu R, Wu H, Wang M, White
BS, Shalloway D and Zheng X: Activation of Src and transformation
by an RPTPα splice mutant found in human tumours. EMBO J.
30:3200–3211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Truffi M, Dubreuil V, Liang X, Vacaresse
N, Nigon F, Han SP, Yap AS, Gomez GA and Sap J: RPTPα controls
epithelial adherens junctions, linking E-cadherin engagement to
c-Src-mediated phosphorylation of cortactin. J Cell Sci.
127:2420–2432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng SY, Sun G, Schlaepfer DD and Pallen
CJ: Grb2 promotes integrin-induced focal adhesion kinase (FAK)
autophosphorylation and directs the phosphorylation of protein
tyrosine phosphatase α by the Src-FAK kinase complex. Mol Cell
Biol. 34:348–361. 2014. View Article : Google Scholar :
|
|
20
|
Buist A, Blanchetot C, Tertoolen LG and
den Hertog J: Identification of p130cas as an in vivo substrate of
receptor protein-tyrosine phosphatase alpha. J Biol Chem.
275:20754–20761. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lai X, Chen Q, Zhu C, Deng R, Zhao X, Chen
C, Wang Y, Yu J and Huang J: Regulation of RPTPα-c-Src signalling
pathway by miR-218. FEBS J. 282:2722–2734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vacaresse N, Møller B, Danielsen EM, Okada
M and Sap J: Activation of c-Src and Fyn kinases by
protein-tyrosine phosphatase RPTPalpha is substrate-specific and
compatible with lipid raft localization. J Biol Chem.
283:35815–35824. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elsberger B, Fullerton R, Zino S, Jordan
F, Mitchell TJ, Brunton VG, Mallon EA, Shiels PG and Edwards J:
Breast cancer patients' clinical outcome measures are associated
with Src kinase family member expression. Br J Cancer. 103:899–909.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elsberger B, Tan BA, Mallon EA, Brunton VG
and Edwards J: Is there an association with phosphorylation and
dephosphorylation of Src kinase at tyrosine 530 and breast cancer
patient disease-specific survival. Br J Cancer. 103:1831–1834.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qayyum T, McArdle PA, Lamb GW, Jordan F,
Orange C, Seywright M, Horgan PG, Jones RJ, Oades G, Aitchison MA,
et al: Expression and prognostic significance of Src family members
in renal clear cell carcinoma. Br J Cancer. 107:856–863. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roskoski R Jr: Src kinase regulation by
phosphorylation and dephosphorylation. Biochem Biophys Res Commun.
331:1–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tryfonopoulos D, Walsh S, Collins DM,
Flanagan L, Quinn C, Corkery B, McDermott EW, Evoy D, Pierce A,
O'Donovan N, et al: Src: A potential target for the treatment of
triple-negative breast cancer. Ann Oncol. 22:2234–2240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar
|
|
29
|
den Hertog J, Pals CE, Peppelenbosch MP,
Tertoolen LG, de Laat SW and Kruijer W: Receptor protein tyrosine
phosphatase alpha activates pp60c-src and is involved in neuronal
differentiation. EMBO J. 12:3789–3798. 1993.PubMed/NCBI
|
|
30
|
Qi Y, Dai Y and Gui S: Protein tyrosine
phosphatase PTPRB regulates Src phosphorylation and tumour
progression in NSCLC. Clin Exp Pharmacol Physiol. 43:1004–1012.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scrima M, De Marco C, De Vita F, Fabiani
F, Franco R, Pirozzi G, Rocco G, Malanga D and Viglietto G: The
nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor
gene in non-small cell lung cancer. Am J Pathol. 180:1202–1214.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Veeriah S, Brennan C, Meng S, Singh B,
Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, et
al: The tyrosine phosphatase PTPRD is a tumor suppressor that is
frequently inactivated and mutated in glioblastoma and other human
cancers. Proc Natl Acad Sci USA. 106:9435–9440. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lucci MA, Orlandi R, Triulzi T, Tagliabue
E, Balsari A and Villa-Moruzzi E: Expression profile of tyrosine
phosphatases in her2 breast cancer cells and tumors. Cell Oncol.
32:361–372. 2010.PubMed/NCBI
|
|
34
|
Tremper-Wells B, Resnick RJ, Zheng X,
Holsinger LJ and Shalloway D: Extracellular domain dependence of
PTPalpha transforming activity. Genes Cells. 15:711–724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meyer DS, Aceto N, Sausgruber N, Brinkhaus
H, Muller U, Pallen CJ and Bentires-Alj M: Tyrosine phosphatase
PTPα contributes to HER2-evoked breast tumor initiation and
maintenance. Oncogene. 33:398–402. 2014. View Article : Google Scholar
|
|
36
|
Yahiro K, Wada A, Nakayama M, Kimura T,
Ogushi K, Niidome T, Aoyagi H, Yoshino K, Yonezawa K, Moss J, et
al: Protein-tyrosine phosphatase alpha, RPTP alpha, is a
Helicobacter pylori VacA receptor. J Biol Chem. 278:19183–19189.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Krndija D, Schmid H, Eismann JL, Lother U,
Adler G, Oswald F, Seufferlein T and von Wichert G: Substrate
stiffness and the receptor-type tyrosine-protein phosphatase alpha
regulate spreading of colon cancer cells through cytoskeletal
contractility. Oncogene. 29:2724–2738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mueller PR, Coleman TR, Kumagai A and
Dunphy WG: Myt1: A membrane-associated inhibitory kinase that
phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science.
270:86–90. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee RJ, Albanese C, Stenger RJ, Watanabe
G, Inghirami G, Haines GK III, Webster M, Muller WJ, Brugge JS,
Davis RJ, et al: pp60 (v-src) induction of cyclin D1 requires
collaborative interactions between the extracellular
signal-regulated kinase, p38, and Jun kinase pathways. A role for
cAMP response element-binding protein and activating transcription
factor-2 in pp60(v-src) signaling in breast cancer cells. J Biol
Chem. 274:7341–7350. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Riley D, Carragher NO, Frame MC and Wyke
JA: The mechanism of cell cycle regulation by v-Src. Oncogene.
20:5941–5950. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xing J, Zhang Z, Mao H, Schnellmann RG and
Zhuang S: Src regulates cell cycle protein expression and renal
epithelial cell proliferation via PI3K/Akt signaling-dependent and
-independent mechanisms. Am J Physiol Renal Physiol. 295:F145–F152.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu X, Du L and Feng R: c-Src regulates
cell cycle proteins expression through protein kinase B/glycogen
synthase kinase 3 beta and extracellular signal-regulated kinases
1/2 pathways in MCF-7 cells. Acta Biochim Biophys Sin (Shanghai).
45:586–592. 2013. View Article : Google Scholar
|
|
43
|
Berndt A, Luo X, Böhmer FD and Kosmehl H:
Expression of the transmembrane protein tyrosine phosphatase
RPTPalpha in human oral squamous cell carcinoma. Histochem Cell
Biol. 111:399–403. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tabiti K, Smith DR, Goh HS and Pallen CJ:
increased mRNA expression of the receptor-like protein tyrosine
phosphatase alpha in late stage colon carcinomas. Cancer Lett.
93:239–248. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ardini E, Agresti R, Tagliabue E, Greco M,
Aiello P, Yang LT, Ménard S and Sap J: Expression of protein
tyrosine phosphatase alpha (RPTPalpha) in human breast cancer
correlates with low tumor grade, and inhibits tumor cell growth in
vitro and in vivo. Oncogene. 19:4979–4987. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Junnila S, Kokkola A,
Karjalainen-Lindsberg ML, Puolakkainen P and Monni O: Genome-wide
gene copy number and expression analysis of primary gastric tumors
and gastric cancer cell lines. BMC Cancer. 10:732010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wu CW, Kao HL, Li AF, Chi CW and Lin WC:
Protein tyrosine-phosphatase expression profiling in gastric cancer
tissues. Cancer Lett. 242:95–103. 2006. View Article : Google Scholar
|
